Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lamarca

Showing results (161-170 of 201) with videos related to

Pageof 21
Sort By:
The Oncologist|December 10, 2020
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, et al.
Hepatology (Baltimore, Md.)|May 17, 2021
REPLYAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.
Journal of Hepatology|July 5, 2026
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE studyDo-Youn Oh, Masafumi Ikeda, Teresa Macarulla, et al.
Hepatology (Baltimore, Md.)|February 7, 2021
REPLYAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.
Hepatology (Baltimore, Md.)|October 19, 2020
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging SystemAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Cancers|August 27, 2021
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?Melissa Frizziero, Alice Durand, Rodrigo G Taboada, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 12, 2018
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in EuropeMuhammad Ahsan Javed, Georg Beyer, Nha Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 StudyAngela Lamarca, Maxime Ronot, Salma Moalla, et al.
Pageof 21

Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
The Oncologist|December 10, 2020
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, et al.
Hepatology (Baltimore, Md.)|May 17, 2021
REPLYAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
The Oncologist|March 27, 2019
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET StudyAngela Lamarca, Joakim Crona, Maxime Ronot, et al.
Journal of Hepatology|July 5, 2026
Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE studyDo-Youn Oh, Masafumi Ikeda, Teresa Macarulla, et al.
Hepatology (Baltimore, Md.)|February 7, 2021
REPLYAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Neuroendocrinology|July 28, 2020
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of VariabilityClarisse Dromain, Anders Sundin, Pavan Najran, et al.
Hepatology (Baltimore, Md.)|October 19, 2020
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging SystemAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Cancers|August 27, 2021
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?Melissa Frizziero, Alice Durand, Rodrigo G Taboada, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 12, 2018
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in EuropeMuhammad Ahsan Javed, Georg Beyer, Nha Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 StudyAngela Lamarca, Maxime Ronot, Salma Moalla, et al.
Pageof 21